SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute 
Nvidia Develops New Location-Verification Technology for AI Chips 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs 
JD.com Pledges 22 Billion Yuan Housing Support for Couriers as China’s Instant Retail Competition Heats Up 
Rio Tinto Signs Interim Agreement With Yinhawangka Aboriginal Group Over Pilbara Mining Operations 
Samsung SDI Secures Major LFP Battery Supply Deal in the U.S. 
Air Transat Reaches Tentative Agreement With Pilots, Avoids Strike and Restores Normal Operations 
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute 
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies 
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
GameStop Misses Q3 Revenue Estimates as Digital Shift Pressures Growth 
Gulf Sovereign Funds Unite in Paramount–Skydance Bid for Warner Bros Discovery 
FORT LAUDERDALE, Fla., Aug. 09, 2017 -- OmniComm Systems, Inc., (OTCQX:OMCM), a leading global provider of clinical data management technology, has a new technology partner in Japan. SRD Co., Ltd., a contract research organization (CRO) in Tokyo, has selected OmniComm’s TrialMaster electronic data capture (EDC) technology to support clinical trial research for pharmaceutical, medical devices and related healthcare products. The agreement represents the first contract for TrialMaster in Japan.
“SRD selected TrialMaster EDC because it offers efficient and easy support, and provides site users with easy-to-use data entry screens that support high-quality data capture and avoid unnecessary system-generated queries,” said Akira Sugihara, general manager of SRD’s data science department. “In addition, OmniComm provides excellent support – in the local language – for our study-build activities, operational challenges and our business development activities.”
TrialMaster was selected for its speed of study build, flexibility and multilingual capabilities, but most of all, for its unique ability to both transpose data and export data in SDTM format directly from the EDC solution. Compelling TrialMaster features include: intuitive user interface, real-time edit checks, real-time reporting and the ability to customize data exports. OmniComm’s technology transition deployment model, which allows customers to build their studies while OmniComm manages the hosting in its state-of-the-art data centers, was another critical factor in the selection process.
“We started preparing to bring TrialMaster to the Japanese market in 2016. In Japan, more so than any other country, it requires not only a superior product, but above all, endurance and focus to bring a new technology to the market and secure your first customers,” said Wolf Ondracek, senior vice president at OmniComm, with responsibility for the Asia-Pacific region. “The fact that SRD, a local Japanese CRO, has chosen TrialMaster as its EDC system for industry-sponsored trials is a tremendously important milestone. I am confident that it marks the start of the successful penetration of the Japanese market for our flagship EDC solution, TrialMaster.”
Specific emphasis for TrialMaster’s selection included:
- Ability to build studies more efficiently and effectively.
- Adeptness in query management work flow.
- Intuitive interface for all key user groups.
- Dynamic monitoring and centralized source review.
- Ability to export SDTM datasets directly from TrialMaster using Custom Export Utility Tool™.
- Broad range of pre-built, real-time standard reports and best-in-class, real-time ad-hoc reporting.
- Flexible and very user-friendly eLearning modules.
- Professional and experienced regional-based services and support organization.
Supporting Information
- OmniComm Systems Signs Fifth TrialOne Contract in China in Four Months
- OmniComm Systems® Announces the Go-Live of TrialOne® at Seoul National University Hospital
- OmniComm Systems Experiencing Rapid Adoption of TrialOne® in China
- OmniComm Systems Announces First Australia Client
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 5,000 clinical trials. For more information, please visit: omnicomm.com
About SRD Co., Ltd.
SRD is a Tokyo-based, mid-size Japanese CRO, established in 1989. The company offers a full range of CRO services, including monitoring, QA and GCP services, data management and biostatistics, drug management, medical writing, pharmacovigilance and regulatory consulting. For further details, please visit: http://www.cro-srd.co.jp/
Trademarks
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact Info Kuno van der Post OmniComm Systems, Inc. +1.954.473.1254 [email protected]
